Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronary Artery Disease: later-stage trial registry
57 of 220 indexed Coronary Artery Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #42 of 28,707 conditions by registered trial count.
220 US clinical trials · 57 currently recruiting · #42 of 28,707 conditions by registered trial count
Coronary Artery Disease: 220 US clinical trials tracked, 57 recruiting.
Coronary Artery Disease is the subject of 220 registered US clinical trials on ClinicalTrials.gov, 57 of them currently open to new participants. 42 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is University of Florida, running 17 of these trials.
Enrollment posture brief
Registry condition coronary-artery-disease
OPEN 57 | RECR 26% | LATE 42 | EARLY 15 | RANK #42 | SPON 17
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma (26% recruiting · 27 trials)
Coronary Artery Disease lists 57 open slots (26% of 220 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronary Artery Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronary Artery Disease is recruiting below its size-band peers.
57 of 220 indexed trials (25.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Coronary Artery Disease trials is spread across many organizations.
University of Florida accounts for 17 of 220 trials (7.7%). 134 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronary Artery Disease enrolment sits around 266 participants.
Median target enrolment is 266 among the 220 trials that report a genuine target (sentinel values excluded). 70 of those (31.8%) plan for fewer than 100 participants.
-
Coronary Artery Disease splits between interventional and observational designs.
153 interventional and 67 observational studies make up this index (69.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
220 total, page 5 of 5
Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography
Paieon
NCT00973921
Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)
Cedars-Sinai Medical Center
NCT00892307
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)
University of Louisville
NCT00474461
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
AstraZeneca
NCT03400488
The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina
Takeda
NCT01763996
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
National Human Genome Research Institute (NHGRI)
NCT01369953
Peripheral Nerve Blocks for Above-the-knee Amputations
University of Florida
NCT03404180
A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease
Fluoropharma
NCT00413647
PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
Washington University School of Medicine
NCT05349084
Reversing Ticagrelor's Effects With Fresh Platelets
Icahn School of Medicine at Mount Sinai
NCT02201394
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Lancaster General Hospital
NCT02756234
Evaluation of MyoStrain™ in Clinical Practice
University of Kansas Medical Center
NCT03825224
Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor
University of Florida
NCT04668495
Effect of Cocoa Flavanols on Vascular Function
University of California, San Francisco
NCT00553774
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
University of Florida
NCT03489863
Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)
National Heart, Lung, and Blood Institute (NHLBI)
NCT02303067
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
Abbott Medical Devices
NCT02229864
Evaluation of Coronary Artery Calcification Using Gated Stationary Chest Tomosynthesis
University of North Carolina, Chapel Hill
NCT03169062
Assessment Of Vascular Health After Niacin Therapy (AVANT)
University of Pennsylvania
NCT02003638
Identification of Adverse Plaque Characteristics by Coronary MR Angiography
Cedars-Sinai Medical Center
NCT01986868
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 9 |
| Phase 3 | 17 |
| Phase 4 | 25 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronary Artery Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronary Artery Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronary Artery Disease page
220 registered trials, 57 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 57 Coronary Artery Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Florida sponsors the most Coronary Artery Disease trials on record, review their full trial history before evaluating a specific study. See University of Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Artery Disease condition card totals 220 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.